BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
CRISPR Therapeutics
CRSP
$5.21B
| $74.4M | ﹤0.01% |
1,012,817
+399,288
| +65% | +$23.3M |
|
2027
TriMas Corp
TRS
$1.45B
| $74.4M | ﹤0.01% |
3,107,421
-115,844
| -4% | -$2.66M |
|
2028
Arvinas
ARVN
$596M
| $74.2M | ﹤0.01% |
2,212,309
+426,899
| +24% | +$18.1M |
|
2029
National Presto Industries
NPK
$996M
| $73.7M | ﹤0.01% |
843,858
+2,410
| +0.3% | +$205K |
|
2030
E.W. Scripps
SSP
$305M
| $73.5M | ﹤0.01% |
8,402,595
+29,282
| +0.3% | +$235K |
|
2031
Cactus
WHD
$5.72B
| $73.5M | ﹤0.01% |
3,563,362
+243,199
| +7% | +$4.22M |
|
|
DTP
2032
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $73.3M | ﹤0.01% |
1,732,905
-124,037
| -7% | -$5.13M |
|
2033
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
| $73.3M | ﹤0.01% |
1,695,592
-244,843
| -13% | -$10M |
|
2034
Workhorse Group
WKHS
$34.6M
| $73.2M | ﹤0.01% |
1,404
+1,020
| +266% | +$11.1M |
|
2035
Brookfield Infrastructure
BIPC
$4.81B
| $73.2M | ﹤0.01% |
+2,411,060
| New | +$70M |
|
|
ABTX
2036
DELISTED
Allegiance Bancshares
ABTX
| $73.1M | ﹤0.01% |
2,879,072
-59,714
| -2% | -$1.46M |
|
2037
First Busey Corp
BUSE
$2.57B
| $73M | ﹤0.01% |
3,915,387
+151,984
| +4% | +$2.63M |
|
2038
Quanex
NX
$994M
| $73M | ﹤0.01% |
5,259,869
+16,180
| +0.3% | +$193K |
|
2039
Banc of California
BANC
$3.05B
| $72.8M | ﹤0.01% |
6,722,201
-197,287
| -3% | -$1.98M |
|
2040
Enova International
ENVA
$6.42B
| $72.7M | ﹤0.01% |
4,891,350
-381,679
| -7% | -$5.31M |
|
|
ATRI
2041
DELISTED
Atrion Corp
ATRI
| $72.7M | ﹤0.01% |
114,076
+9,197
| +9% | +$6.01M |
|
2042
MGP Ingredients
MGPI
$379M
| $72.4M | ﹤0.01% |
1,971,284
+11,930
| +0.6% | +$427K |
|
2043
Huron Consulting
HURN
$2.36B
| $72.3M | ﹤0.01% |
1,633,142
+42,486
| +3% | +$1.91M |
|
2044
Virgin Galactic
SPCE
$480M
| $72.2M | ﹤0.01% |
220,967
+153,431
| +227% | +$50.4M |
|
2045
Kosmos Energy
KOS
$1.49B
| $72.2M | ﹤0.01% |
43,487,216
+15,076,513
| +53% | +$24.2M |
|
2046
CALL
Apple
AAPL
$4.47T
| $72.1M | ﹤0.01% |
+790,400
| New | +$61.2M |
|
2047
CALL
JPMorgan Chase
JPM
$963B
| $72.1M | ﹤0.01% |
+766,300
| New | +$72.7M |
|
2048
Clarivate
CLVT
$1.29B
| $72M | ﹤0.01% |
3,224,349
+1,386,712
| +75% | +$31.3M |
|
|
CSW
2049
CSW Industrials
CSW
$5.77B
| $72M | ﹤0.01% |
1,041,420
-35,829
| -3% | -$2.42M |
|
|
MDLA
2050
DELISTED
Medallia, Inc.
MDLA
| $71.6M | ﹤0.01% |
2,837,567
+904,097
| +47% | +$21.6M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.